tiprankstipranks
Trending News
More News >
Immucell Corp. (ICCC)
NASDAQ:ICCC
US Market

Immucell (ICCC) Income Statement

Compare
74 Followers

Immucell Income Statement

Last quarter (Q4 2024), Immucell's total revenue was $7.75M, an increase of 52.10% from the same quarter last year. In Q4, Immucell's net income was $515.00K. See Immucell’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 26.49M$ 17.47M$ 18.57M$ 19.24M$ 15.34M
Gross Profit
$ 7.94M$ 4.40M$ 7.65M$ 8.66M$ 6.86M
Operating Expenses
$ 9.58M$ 10.14M$ 9.95M$ 8.40M$ 8.24M
Depreciation and Amortization
$ 2.68M$ 2.72M$ 2.49M$ 2.47M$ 2.36M
EBITDA
$ 1.04M$ -2.50M$ 349.99K$ 2.72M$ 1.65M
Operating Income
$ -1.64M$ -5.75M$ -2.30M$ -2.20M$ -1.38M
Other Income/Expenses
$ -507.00K$ -21.89K$ -187.19K$ -326.51K$ 348.10K
Pretax Income
$ -2.15M$ -5.77M$ -2.49M$ -69.00K$ -1.03M
Net Income
$ -2.16M$ -5.77M$ -2.49M$ -78.00K$ -1.02M
Per Share Metrics
Basic EPS
$ -0.26$ -0.75$ -0.32$ -0.01$ -0.14
Diluted EPS
$ -0.26$ -0.75$ -0.32$ -0.01$ -0.14
Weighted Average Shares Outstanding
8.17M 7.70M 7.75M 7.59M 7.21M
Weighted Average Shares Outstanding (Diluted)
8.17M 7.75M 7.75M 7.59M 7.21M
Currency in USD

Immucell Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis